By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development industry is at the forefront o...
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy! Agilex Biolabs is thrilled t...
Research shows that Biotechnology companies have been facing significant challenges – with continual declines in deal making act...
By Dr. Kurt Sales, CSO Introduction Immunological assays are essential in drug development, especially for immunomodulatory...
By Dr. Kurt Sales, CSO Peripheral Blood Mononuclear Cells (PBMC) are critical for the pharmacodynamic assessment of new drug pr...
The Role of Peripheral Blood Mononuclear Cells (PBMCs) in Drug Discovery and Clinical Trials. By Dr. Kurt Sales, CSO In the...
By Dr. Kurt Sales, CSO Oligonucleotides, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have gai...
By Dr. Kurt Sales, CSO In the high-stakes world of drug development, biotech companies face unique challenges at every stage -...
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...
By Dr. Kurt Sales, CSO Biomarkers are playing an increasingly important role in clinical studies where they can provide essenti...
by Dr. Kurt Sales, Chief Scientific Officer Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been the preferred an...
